Comunicati Stampa
Industria

India In-vitro Fertilization Market 2029: Surprising Facts and Future Projections Exposed

The India In-vitro Fertilization (IVF) market stood at USD 845.07 million in 2023. It is anticipated to grow at a compound annual growth rate (CAGR) of 8.92% from 2025 to 2029
Manhattan , (informazione.it - comunicati stampa - industria)

Introduction

According to the TechSci Research report, "India In-vitro Fertilization Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029," the India In-vitro Fertilization (IVF) market stood at USD 845.07 million in 2023. It is anticipated to grow at a compound annual growth rate (CAGR) of 8.92% from 2025 to 2029. This growth is driven by multiple factors, including the increasing incidence of infertility, technological advancements in IVF procedures, government initiatives promoting medical tourism, and the cost-effectiveness of IVF in India compared to other countries.

 

What Drives the Growth of the IVF Market in India?

Lifestyle Changes and Increasing Infertility Rates

The increasing incidence of infertility due to lifestyle changes, such as delayed childbearing and rising stress levels, is a significant driver of the IVF market in India. Infertility, defined as the inability to conceive after a year of trying, affects approximately 10-14% of the Indian population. The American Pregnancy Association reports that male infertility constitutes 30% of overall infertility cases and contributes to approximately one-fifth of all infertility instances in the U.S. This trend is also evident in India, where the average age of marriage and the age of having the first child is increasing, leading more women to seek IVF treatment. Additionally, many women are choosing to freeze their eggs to focus on their careers and have children at a later stage, further driving the demand for IVF procedures.

 

Browse Full Report – https://www.techsciresearch.com/report/india-in-vitro-fertilization-market/4533.html

 

Technological Advancements in IVF Procedures

Technological advancements in IVF, such as time-lapse imaging and preimplantation genetic diagnosis, are propelling the market. Time-lapse imaging allows continuous monitoring of developing embryos without removing them from the incubator, reducing external disturbances and improving the chances of successful implantation. Preimplantation genetic testing enables the identification of genetic defects within embryos, ensuring only healthy embryos are implanted, reducing the risk of genetic disorders, and increasing the overall success rate of IVF cycles.

 

Government Initiatives and Cost-Effectiveness

Government initiatives to promote medical tourism, combined with the cost-effectiveness of IVF procedures in India compared to other countries, are attracting patients globally. The rise in disposable income and increased awareness about IVF among the general population are also significant factors contributing to the market's growth.

 

How Does the Regulatory Scenario Shape this Industry?

Regulatory Framework

The regulatory scenario in India plays a crucial role in shaping the IVF industry. The Assisted Reproductive Technology (ART) Regulation Bill, which aims to regulate and supervise ART clinics and banks, was passed in 2020. This bill ensures that ART services are ethical, safe, and effective, providing a structured framework for the industry.

 

Impact of Regulations on Market Dynamics

Regulations ensure that IVF procedures are carried out ethically and safely, instilling confidence in patients and healthcare providers. The regulatory framework also promotes transparency and accountability, which are essential for the industry's growth. However, the lack of insurance coverage for IVF procedures remains a challenge, making the treatments less accessible to a broader population.

 

Emerging Trends in the Indian IVF Market

Adoption of AI and Machine Learning

The integration of artificial intelligence (AI) and machine learning in IVF processes is a notable trend. AI tools are being used for improved embryo selection, personalized treatment protocols, and remote patient monitoring. For instance, AIVF Ltd. and Genea Biomedx's collaboration brought together Genea Biomedx’s Geri time-lapse incubator and AIVF Ltd.’s EMA AI platform, creating a powerful suite that offers widespread access to personalized and optimized IVF treatments.

 

Expansion of IVF Services to Tier 2 and Tier 3 Cities

The expansion of IVF services to Tier 2 and Tier 3 cities is another emerging trend. Leading IVF chains like Cloudnine and Indira IVF are opening new centers across various cities in India, increasing the accessibility of IVF services. This expansion is expected to create lucrative opportunities for the market.

 

Top 10 Companies in the Indian IVF Market

  1. Merck India
  2. ORIGIO India Pvt Ltd.
  3. IMV India Pvt. Ltd.
  4. Thermo Fisher Scientific India Pvt. Ltd.
  5. Travancore Trade Links
  6. Cook Medical India
  7. Morpheus Life Sciences Pvt. Ltd.
  8. Max Healthcare Institute Limited
  9. Olympus Medical Systems India Pvt Ltd.
  10. FUJIFILM India Pvt Ltd.

 

Discover Who You Really Compete Against In The Marketplace, Get PDF Sample Report Now! @ https://www.techsciresearch.com/sample-report.aspx?cid=4533

 

Top Segments in the Indian IVF Market

Technique

  • Intracytoplasmic Sperm Injection (ICSI) IVF: ICSI IVF is projected to dominate the market due to its higher success rate compared to Non-ICSI/Traditional IVF. This technique is particularly beneficial in cases of severe male infertility.
  • Non-ICSI/Traditional IVF: Though less popular than ICSI, traditional IVF still holds a significant market share.

Product

  • IVF Culture Media
  • ICSI Machine
  • IVF Incubators
  • Cryosystem
  • Others

Donor

  • Fresh Non-donor
  • Frozen Non-donor
  • Fresh Donor
  • Frozen Donor

Infertility

  • Male
  • Female

Embryo

  • Fresh Embryo
  • Frozen-thawed Embryo

End User

  • Fertility Clinics
  • Hospitals
  • Others

Region

  • North India
  • West India
  • South India
  • East India

Industry Key Highlights

  • The India IVF market stood at USD 845.07 million in 2023.
  • The market is anticipated to grow at a CAGR of 8.92% from 2025 to 2029.
  • The increasing incidence of infertility, technological advancements in IVF, government initiatives, and cost-effectiveness are major growth drivers.
  • Regulatory frameworks ensure ethical and safe ART services, promoting market growth.
  • Emerging trends include the adoption of AI and machine learning and the expansion of IVF services to Tier 2 and Tier 3 cities.

 

Future Outlook

The future of the Indian IVF market appears promising, driven by an increasing prevalence of infertility, advancements in technology, and a growing acceptance of IVF procedures. Trends suggest a progressive rise in the use of assisted reproductive technology due to changing socio-cultural attitudes. However, the high cost of IVF procedures and the lack of insurance coverage continue to be deterrents for many couples.

Despite these challenges, the rising middle-class population and their increasing disposable income are expected to provide ample opportunities for the expansion of the IVF market in India. Ongoing technological advancements will continue to enhance treatment outcomes, while growing awareness and acceptance will further expand the market. The challenge remains in making these treatments more accessible and affordable to unlock the market's full potential. 

Recent Developments

  • June 2023: FUJIFILM Irvine Scientific expanded its Presagen’s Life Whisperer platform capabilities to assist with clinical decision-making in IVF.
  • May 2023: Merck KGaA introduced Fertility Counts to address societal, economic, and social challenges associated with low birth rates in the Asia Pacific (APAC) region.
  • May 2023: Ovation Fertility combined with US Fertility to create a platform offering advanced fertility care and IVF services in the U.S.
  • April 2023: Boston IVF signed a 3-year supply chain solutions agreement with Cryoport, Inc. to support reproductive material shipment across the U.S.
  • October 2023: Cloudnine and Indira IVF announced expansions by opening new centers across various cities in India, focusing on increasing accessibility of IVF services in Tier 2 and Tier 3 cities.
  • August 2023: Fortis Fertility and Janin Biosciences integrated AI and machine learning into their IVF processes for improved embryo selection, personalized treatment protocols, and remote patient monitoring.
  • January 2021: Nova IVF Fertility expanded its network in NCR through a strategic partnership with Southend Fertility & IVF, significantly increasing its presence in the region.

 

The India In-vitro Fertilization Market is poised for significant growth, driven by rising infertility rates, technological advancements, government initiatives, and increasing awareness and acceptance of IVF treatments. While challenges such as high costs and lack of insurance coverage persist, the market's future looks promising with ample opportunities for expansion and innovation. This comprehensive report provides valuable insights and strategic recommendations for stakeholders to navigate and capitalize on the dynamic IVF market in India.

 

Download Free Sample Report Here: (Including Full TOC, List of Tables & Figures, Chart) - https://www.techsciresearch.com/sample-report.aspx?cid=4533

  

Per maggiori informazioni
Ufficio Stampa
Kumar Satyam
 Techsci Research (Leggi tutti i comunicati)

satyamtechsci@gmail.com
Allegati
Non disponibili